NXTM Financial Facts

Selling and marketing: 13.87M
General and administrative: 8.38M
See Full Income Statement

Total stockholders' equity: 186.1M
Total liabilities and stockholders' equity: 309.21M
See Full Balance Sheet

Nxstage Medical, Inc. (NXTM) Earnings

  |   Expand Research on NXTM
Next EPS Date N/A EPS Growth Rate +100.0% *Last Qtr.
Average EPS % Beat Rate +1.5% Revenue Growth Rate -100.0% *Last Qtr.
Average % Move 1-Wk after EPS +4.9% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
9/30/14 Q314 N/A-$0.13 N/A N/A$71.72M N/A N/A
8/7/14 Q214 -$0.12-$0.11 -$0.01$74.1M$70.52M Details
5/8/14 Q114 -$0.09-$0.11 +$0.02$72.2M$69.44M Details
2/27/14 Q413 -$0.08-$0.09 +$0.01$69.4M$67.66M Details
11/7/13 Q313 -$0.08-$0.07 -$0.01$66.9M$66.77M = Details
7/25/13 Q213 -$0.06-$0.07 +$0.01$65.5M$64.66M = Details
2/28/13 Q412 $0.00-$0.05 +$0.05N/A$63.54M = Details
5/2/13 Q113 -$0.08-$0.08 $0.00$61.6M$61.14M = Details